The American Cancer Society honored Kaiser Permanente’s Theodore R. Levin, MD, for his leadership in raising the health care system’s screening rates for colorectal cancer to among the highest in the nation, at its 6th annual Jewel Ball on Saturday,…
Colleagues celebrate Collen’s life and work at American Medical Informatics Association conference in San Francisco Nov. 15 The last published work of Morris F. Collen, MD, one of the original founding doctors of Kaiser Permanente, has been published almost exactly…
Kaiser Permanente study also shows barriers remain In the first trial to compare different approaches to delivering substance use and mental health screening in primary care for adolescents, training for physicians and embedding behavioral health clinicians produced better results than…
A large study with follow-up over 14 years offers a unique way of looking at the risk of cancer among HIV-positive individuals by accounting for the competing risk of death in the era of highly effective antiretroviral therapy (ART), as…
Findings support planning children at least two years apart Second-born children who are conceived sooner than two years or later than six years after the arrival of their older sibling have a substantially increased risk of autism spectrum disorders (ASDs),…
Patients from all racial and ethnic minority groups who ordered their prescription refills through an online patient portal had better medication adherences, according to a new study in the Journal of the American Medical Informatics Association. “Our findings are consistent…
The timely administration of a clot-dissolving treatment for emergency department patients with acute ischemic stroke nearly doubled following the introduction of new technology that enabled electronic order entry and offered care-decision support for physicians, according to a study published today…
In one of the first and largest published evaluations of the use of preexposure prophylaxis (known as PrEP) to prevent HIV infection in a clinical practice setting, researchers at Kaiser Permanente found no new HIV infections among patients during more…
PORTAL (Patient Outcomes Research to Advance Learning), led Elizabeth McGlynn, PhD, director of Kaiser Permanente's Center for Effectiveness and Safety Research, has been approved for a three-year, $8.6 million funding award by the Patient-Centered Outcomes Research Institute (PCORI). The contract is part of…
A commonly prescribed diabetes medication called pioglitazone (brand name Actos) was not associated with a clear increased risk of bladder cancer and several other cancers, according to a 10-year study conducted at Kaiser Permanente Northern California by researchers at its…
